期刊文献+

应用改良seldinger技术在犬股动脉内置入动脉鞘的实验研究 被引量:1

Application of modified seldinger technique in arterial sheath placement of canine femoral artery
原文传递
导出
摘要 目的:探究seldinger技术经相应改良后能否安全有效地应用于犬股动脉的动脉鞘管置入。方法:30只犬随机分成两组,试验组(n=15)应用改良seldinger技术进行右侧股动脉鞘置入,对照组(n=15)采用股动脉切开法行动脉鞘置管,比较两组右股动脉穿刺成功率、置管时间、出血量和血肿发生率。结果:右股动脉穿刺成功率两组无显著差异(试验组100%vs对照组93.3%),置管时间和出血量试验组显著低于对照组(1.971.06分钟vs7.302.35分钟,7.474.89mlvs20.13.9ml),试验组两例发生小血肿,对照组无血肿发生。结论:改良seldinger技术可安全简便地应用于犬股动脉鞘的置入。 Objective:To approach the feasibility of sheath insertion into canine femoral artery with modified seldinger technique.Methods:A total of thirty dogs were randomly divided into the test group (insertion sheath with modified seldinger technique, n=15) or the control group(insertion sheath with arteriotomy, n=15).success rate of sheath insertion, insertion time, bleeding volume and incidence rate of hematoma were measured.Results:There was no significant difference in success rate of sheath insertion and incidence rate of hematoma between the test group and the control group(100% vs 93.3% and 13.2% vs 0, respectively).Insertion time and bleeding volume of the test group were significantly less than the control group(1.97 1.06 min vs 7.30 2.35 min and 7.47 4.89ml vs 20.1 3.9ml, respectively).Conclusion:Insertion of sheath into canine femoral artery with modified seldinger technique is convenient and safety.
出处 《现代生物医学进展》 CAS 2010年第15期2865-2866,2879,共3页 Progress in Modern Biomedicine
关键词 改良SELDINGER技术 动脉切开法 动脉鞘置入 Canine Modified seldinger technique Arteriotomy Femoral artery sheath insertion
  • 相关文献

参考文献9

  • 1Lejeune P, Deloof T, Leeman M, et al. Multipoint pulmonary vascular pressure/flow relationships in hypoxic and in normoxic dogs: effects of nitrous oxide with and without cyclooxygenase inhibition[J]. Anes- thesiology. 1988,68(1):92-99.
  • 2Eisenbud D, Parsonnet V, Wiktor D, et al. A polyester intravascular stent for maintaining luminal patency: a gross and microscopic study of the device's incorporation, early maturation, and thrombogenicity[J]. Tex Heart lnst J. 1988,15(1):12-16.
  • 3Rapold HJ, Wu ZM, Stassen T, et al. Comparison of intravenous bolus injection or continuous infusion of recombinant single chain uroki- nase-type plasminogen activator (saruplase) for thrombolysis. A canine model of combined coronary arterial and femoral venous thrombosis. Blood[J]. 1990,76(8): 1558-1563.
  • 4Hegde UN, Khanapet MS, Rajapurkar MM et al. Is carbon dioxide a safe and good alternative for diatrizoate meglumine as a contrast in digital subtraction angiography? Indian J Nephrol [J]. 2009,19 (1): 15-19.
  • 5Liu JB, Wansaicheong G, Merton DA, et al. Canine prostate: contrast-enhanced US-guided radiofrequency ablation with urethral and neurovascular cooling-initial experience. Radiology[J]. 2008,247(3): 717-725.
  • 6SELDINGER SI. Catheter replacement of the needle in percutaneous arteriography; a new technique[J]. Acta radiol. 1953,39:368-376.
  • 7江洪,黄从新,王洪如,漆曙辉,唐其柱,李庚山.支架携带放射性核素能力的实验研究[J].中国介入心脏病学杂志,2001,9(2):107-109. 被引量:6
  • 8朱锐,江洪,李庚山,漆曙辉,王小红,王洪如,叶泽兵.冠状动脉内置入国产支架的动物实验研究[J].中国介入心脏病学杂志,2001,9(1):50-52. 被引量:3
  • 9黄国明,李庚山,朱刚艳,赖亦木,张宏祥,王晶,王洪如.冠状动脉内导入裸人心钠素质粒DNA的安全性和生物活性(英文)[J].Acta Pharmacologica Sinica,2002,23(7):609-611. 被引量:1

二级参考文献10

  • 1[1] Roubin GS, Robinson KA, King SB, et al. Early and later results of intracoronary arterial stenting after coronary angioplasty in dogs. Circulation, 1987,76:891-897.
  • 2[2] Schatz RA, Palmaz JC, Tio FO, et al. Bolloon-expandable intracoronary stents in the adult dog. Circulation, 1987,76:450-457.
  • 3[3] Palmaz JC. Intravascular stents: tissue-stent interaction and design. AJR, 1993,160:613-618.
  • 4[1]Nath R, Amols H, Coffey C, et al. Intravascular brachytherapy physics: report of the AAPM radiation therapy committee task group No. 60. American Association of Physicists in Medicine. Med Phys, 1999,26:119-152.
  • 5[2]Wardeh AJ, Kay IP, Sabate M, et al. Beta-particle-emitting radioactive stent implantation. A safety and feasibility study. Circulation, 1999:100:1684-1689.
  • 6[3]Albiero R, Adamian M, Kobayashi N, et al. Short- and intermediate-term results of (32)P radioactive beta-emitting stent. Implantation in patients with coronary artery disease: the milan dose-response study. Circulation, 2000:101:18-26.
  • 7Wilkins MR, Redondo J, Brown LA. The natriuretic peptide family. Lancet 1997; 349:1307 - 10.
  • 8Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, et al. Gene therapy for myocardial angiogenesis initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998; 98:2800 - 4.
  • 9March KL, Woody M, Mehdi K, Zipes DP, Brantly M,Trapnell BC. Efficient in vivo catheter-based pericardial gene transfer mediated by adenoviral vectors. Clin Cardiol 1999;22 (1 Suppl 1): I23-9.
  • 10Barr E, Carroll J, Kalynych AM, Tripathy SK, Kozarsky K,Wilson JM, et al. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther 1994; 1: 51-8.

共引文献7

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部